| Date Filed | Type | Description |
| 06/08/2023 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 09/26/2022 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 97,063 options to buy
@ $0.9152, valued at
$88.8k
|
|
| 06/09/2022 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $0.45, valued at
$9k
|
|
| 09/13/2021 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 22,812 options
@ $3.97, valued at
$90.6k
|
|
| 06/03/2021 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $3.37, valued at
$67.7k
|
|
| 09/17/2020 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 15,024 options
@ $5.99, valued at
$90k
Granted 14,987 options
@ $5.99, valued at
$89.8k
|
|
| 09/17/2020 |
3
| ROGERS MICHAEL W (Director) has filed a Form 3 on Aravive, Inc. |
| 06/09/2020 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 05/16/2019 |
4
| ROGERS MICHAEL W (See Remarks) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 169,500 options to buy
@ $1.04, valued at
$176.3k
Granted 430,500 options to buy
@ $1.04, valued at
$447.7k
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 11,229 shares
@ $0
Granted 18,716 options to buy
@ $12.48, valued at
$233.6k
Granted 11,229 options to buy
@ $15.26, valued at
$171.4k
Granted 11,229 options to buy
@ $17.53, valued at
$196.8k
Granted 11,229 options to buy
@ $10.05, valued at
$112.9k
Granted 25,000 options to buy
@ $8.94, valued at
$223.5k
|
|
| 12/13/2018 |
3
| ROGERS MICHAEL W (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 shares
@ $0
Disposed/sold 140,000 options
@ $0 |
|
| 11/16/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $1.13, valued at
$113k
|
|
| 07/12/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 06/29/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 12,500 restricted stock units
@ $0 |
|
| 06/26/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 26,667 options to buy
@ $1.95, valued at
$52k
Granted 6,667 restricted stock units
@ $0 |
|
| 04/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2017 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 20,000 options to buy
@ $1.77, valued at
$35.4k
Granted 12,500 restricted stock units
@ $0 |
|
| 12/18/2017 |
4
| ROGERS MICHAEL W (CFO) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 293,006 options to buy
@ $5.5, valued at
$1.6M
|
|
| 11/16/2017 |
3
| ROGERS MICHAEL W (CFO) has filed a Form 3 on Aerpio Pharmaceuticals, Inc. |
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/13/2016 |
4
| ROGERS MICHAEL W (CFO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $26.4, valued at
$528k
|
|
| 04/08/2016 |
3
| ROGERS MICHAEL W (Director) has filed a Form 3 on KERYX BIOPHARMACEUTICALS INC |
| 10/09/2013 |
4
| ROGERS MICHAEL W (CFO) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 45,600 shares
@ $0
Granted 136,900 options to buy
@ $35.91, valued at
$4.9M
|
|
| 10/09/2013 |
3
| ROGERS MICHAEL W (CFO) has filed a Form 3 on ACORDA THERAPEUTICS INC |
| 02/11/2013 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC |
| 12/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|